Skip to content
AnalystLens
Back to IDXXBalance Sheet

IDEXX Laboratories Shares Outstanding 2014-2026 | IDXX

Annual FY2014–FY2025 · quarterly through Q3 FY2026

Latest annual · FY2025

79.7M

−2.3%YoY vs FY2024Source: 10-KFY2025

From 47.4M in FY2014 to 79.7M in FY2025: 1.7× in 11 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY2679M−1.9%79M−1.6%79M−1.5%Not reported
FY2581M−2.6%80M−2.8%80M−2.5%80M−2.3%
FY2483M−0.2%82M−0.7%82M−1.2%82M−1.7%
FY2383M−1.4%83M−0.4%83M+0.1%83M+0.2%
FY2284M−1.4%83M−2.0%83M−2.2%83M−2.0%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionStable
CAGR

−1.4%

FY2020
85.4M
FY2025
79.7M

5 years selected · on the chart

Shares Outstanding History

Year-over-year comparison from 10-K annual reports

  1. 79.7M
YoY changeLargest recent move+83.9%in FY17Latest −2.3%

Shares Outstanding, period by period

PeriodValueChangeSource
FY202579.7M−2.3%10-K
FY202481.6M−1.7%10-K
FY202383.0M+0.2%10-K
FY202282.9M−2.0%10-K
FY202184.6M−1.0%10-K
FY202085.4M0.0%flat10-K
FY201985.5M−0.7%10-K
FY201886.1M−1.2%10-K
FY201787.1M+83.9%10-K
FY201447.4M—10-K

What is shares outstanding?

Shares outstanding is the total number of common shares currently held by all shareholders, including restricted shares.

What is IDEXX Laboratories's current shares outstanding?

IDEXX Laboratories (IDXX) annual shares outstanding for 2025 was 79.7M, a 2.32% decline from 2024. IDEXX Laboratories shares outstanding for the quarter ending September 30, 2026 was 78.8M.

What was IDEXX Laboratories's shares outstanding in 2024?

IDEXX Laboratories annual shares outstanding for 2024 was 81.6M, a 1.72% decline from 2023.

What was IDEXX Laboratories's shares outstanding in 2023?

IDEXX Laboratories annual shares outstanding for 2023 was 83.0M, a 0.17% increase from 2022.

What is IDEXX Laboratories's 5-year shares outstanding CAGR?

IDEXX Laboratories shares outstanding grew at a compound annual growth rate (CAGR) of 1.38% from FY2020 to FY2025, going from 85.4M to 79.7M over 5 years.

Company
IDEXX Laboratories
Ticker
IDXX
Sector
Other
Industry
In Vitro & In Vivo Diagnostic Substances